iSpecimen (ISPC) Capital Expenditures (2020 - 2026)

iSpecimen (ISPC) has reported Capital Expenditures for 7 consecutive years, with $700000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Capital Expenditures changed N/A year-over-year to $700000.0; the TTM figure through Mar 2026 stood at $1.7 million (changed N/A YoY), while the FY2025 annual figure was $1.0 million, up 3069.97% from the prior year.
• Capital Expenditures came in at $700000.0 for Q1 2026 at iSpecimen, down from $999546.0 in the prior quarter.
• The five-year high for Capital Expenditures was $3.7 million in Q4 2023, with the low at -$1.5 million in Q2 2023.
• Average Capital Expenditures over 5 years is $651854.6, with a median of $438019.0 recorded in 2022.
• Across the five-year window, Capital Expenditures plunged 448.34% in 2023 and soared 6772.09% in 2025, its largest moves.
• Year by year, Capital Expenditures stood at $1.4 million in 2022, then soared by 162.75% to $3.7 million in 2023, then tumbled by 99.79% to $7865.0 in 2024, then jumped by 12608.79% to $999546.0 in 2025, then retreated by 29.97% to $700000.0 in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $700000.0, $999546.0, and $7865.0 for Q1 2026, Q3 2025, and Q4 2024 respectively.